Clinical and laboratory experience with gram-negative septic shock.
D000328:Adult; D000368:Aged; D000818:Animals; D001794:Blood Pressure; D002196:Capillaries / Q000187:drug effects; D002199:Capillary Permeability; D002302:Cardiac Output; D002496:Central Venous Pressure; D004285:Dogs; D004731:Endotoxins / Q000008:administration & dosage / Q000494:pharmacology; D004837:Epinephrine / Q000494:pharmacology; D005260:Female; D005552:Forelimb / Q000098:blood supply; D006801:Humans; D007082:Ileum / Q000098:blood supply; D066298:In Vitro Techniques; D007275:Injections, Intravenous; D008297:Male; D008775:Methylprednisolone / Q000494:pharmacology; D008875:Middle Aged; D010477:Perfusion; D010643:Phenoxybenzamine / Q000494:pharmacology; D018805:Sepsis / Q000503:physiopathology; D012772:Shock, Septic / Q000188:drug therapy / Q000503:physiopathology*; D014655:Vascular Resistance
D004731:Endotoxins; D010643:Phenoxybenzamine; D008775:Methylprednisolone; D004837:Epinephrine